StonvexLoading…
StonvexCore line items from CCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $856.65M | $789.67M | $4.12B | $2.88B | $1.90B |
Operating Income | Not available | $33.33M | $194.41M | $147.44M | $99.60M |
Net Income | Not available | $24.41M | $147.60M | $111.64M | $74.24M |
EPS (Diluted) | $0.55 | $0.84 | $4.86 | $3.65 | $2.40 |
Total Assets | Not available | $4.51B | $4.46B | $4.69B | $4.58B |
Total Liabilities | Not available | $1.96B | $1.87B | $2.12B | $2.02B |
Cash & Equivalents | Not available | $78.18M | $109.44M | $130.07M | $93.25M |
Free Cash Flow OCF − CapEx | Not available | $-57.09M | $124.31M | $-78.30M | $-57.51M |
Shares Outstanding | Not available | 28.77M | 29.05M | 29.38M | 29.68M |